# Jiangsu Hengrui Medicine
 (stock symbol: 600276.SS) Logo in transparent PNG format

## Jiangsu Hengrui Medicine
 Logo icon format

### Jiangsu Hengrui Medicine
 Logo icon format Download PNG (474.89 KB)

![Jiangsu Hengrui Medicine
 Logo icon format Download PNG (474.89 KB)](/img/orig/600276.SS-d904feda.png)

## About Jiangsu Hengrui Medicine


Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.

1. Website domain: hrs.com.cn
2. Employees: 24491
3. Marketcap: $46.31 Billion USD


## Categories
- [x] ðŸ‡¨ðŸ‡³ China
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
